IO Biotech, Inc. (IOBTQ)

IO Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	30.66	60.03	143.19	142.59	211.53	3.41
Cash & Short-Term Investments	30.66	60.03	143.19	142.59	211.53	3.41
Cash Growth	-61.76%	-58.08%	0.42%	-32.59%	6112.36%	-56.60%
Other Receivables	0.99	1.13	1.13	1.53	2.09	1.5
Receivables	0.99	1.13	1.13	1.53	2.09	1.5
Prepaid Expenses	0.29	1.12	1.35	1.72	3.2	-
Other Current Assets	4.89	2.67	1.58	2.38	4.92	0.73
Total Current Assets	36.83	64.95	147.26	148.22	221.74	5.64
Property, Plant & Equipment	1.85	2.36	3.11	3.23	0.16	-
Other Long-Term Assets	1.28	0.39	0.36	0.35	0.4	0.02
Total Assets	39.96	67.7	150.72	151.81	222.29	5.65

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Accounts Payable	5.59	4.66	3.88	4	3.93	0.52
Accrued Expenses	11.45	13.61	10.62	4.21	5.92	2.27
Current Portion of Leases	0.79	0.72	0.66	0.52	-	-
Other Current Liabilities	0.49	0.5	0.56	1.95	0.46	0.26
Total Current Liabilities	18.31	19.49	15.72	10.68	10.31	3.05
Long-Term Leases	0.67	1.2	1.84	2.28	-	-
Other Long-Term Liabilities	3.4	-	-	-	0.06	-
Total Liabilities	39.05	20.68	17.56	12.95	10.36	3.05

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Common Stock	0.07	0.07	0.07	0.03	0.03	0.03
Additional Paid-In Capital	424.34	413.11	406.59	326.71	319.67	1.11
Retained Earnings	-416.33	-359.31	-263.82	-177.74	-106.28	-38.4
Comprehensive Income & Other	-7.17	-6.85	-9.67	-10.14	-1.49	1.96
Total Common Equity	0.91	47.02	133.16	138.85	211.92	-35.3
Shareholders' Equity	0.91	47.02	133.16	138.85	211.92	2.6
Total Liabilities & Equity	39.96	67.7	150.72	151.81	222.29	5.65

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	18.12	1.92	2.49	2.79	-	-
Net Cash (Debt)	12.55	58.12	140.7	139.8	211.53	3.41
Net Cash Growth	-83.95%	-58.70%	0.64%	-33.91%	6112.36%	-
Net Cash Per Share	0.19	0.88	3.23	4.85	48.79	19.22
Filing Date Shares Outstanding	71.95	65.88	65.88	28.82	28.82	0.18
Total Common Shares Outstanding	69.69	65.88	65.88	28.82	28.82	0.18
Working Capital	18.52	45.47	131.54	137.54	211.43	2.59
Book Value Per Share	0.01	0.71	2.02	4.82	7.35	-199.23
Tangible Book Value	0.91	47.02	133.16	138.85	211.92	-35.3
Tangible Book Value Per Share	0.01	0.71	2.02	4.82	7.35	-199.23
Machinery	1.32	1.22	1.18	0.86	0.17	-

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 28, 2026

Data Sources Report a data error